Publication:
mTOR signaling alters cell fate following inhibition of cyclin-dependent kinases due to androgen receptor status in prostate cancer cells

dc.contributorFen Edebiyat Fakültesi / Faculty of Letters and Sciences Moleküler Biyoloji ve Genetik / Molecular Biology and Geneticstr_TR
dc.contributor.authorBerrak, Özge
dc.contributor.authorÇoker Gürkan, Ajda
dc.contributor.authorÜnsal, Zeynep Narçin
dc.contributor.authorARISAN, ELİF DAMLA
dc.contributor.authorYERLİKAYA, PINAR OBAKAN
dc.contributor.authorID113920tr_TR
dc.contributor.authorID156421tr_TR
dc.contributor.authorID125860tr_TR
dc.date.accessioned2019-02-05T08:53:04Z
dc.date.available2019-02-05T08:53:04Z
dc.date.issued2014
dc.identifier.urihttps://hdl.handle.net/11413/4440
dc.language.isoen_UStr_TR
dc.relationInternational Journal of Molecular MedicineThe 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medecinetr_TR
dc.titlemTOR signaling alters cell fate following inhibition of cyclin-dependent kinases due to androgen receptor status in prostate cancer cellstr_TR
dc.typeconferenceObjecttr_TR
dspace.entity.typePublication
relation.isAuthorOfPublication3d33e154-a50c-46b8-ad6e-25a26bf11cf0
relation.isAuthorOfPublication387670e2-5a88-4937-b3da-1dda9aedfbdd
relation.isAuthorOfPublication.latestForDiscovery3d33e154-a50c-46b8-ad6e-25a26bf11cf0

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: